History


2013

2013

In July 2013, Melan Bio was established and successfully approved more than 120 acres of land for the plant.

2014

2014

In September 2014, Melan Bio-vaccine Factory started to prepare for construction, and the first phase invested 350 million yuan successively.

2015

2015

Established the Melan Biological Research Institute in July 2015

2017

2017

Melan Bio-vaccine Production Line Successfully Passed GMP Static Acceptance of Ministry of Agriculture in March 2017

In November 2017, Melan Bio-vaccine production line passed the dynamic acceptance of GMP of the Ministry of Agriculture.

2018

2018

In January 2018, Melan Bio obtained GMP certificate and production license for biological products.

In October 2018, Melan was recognized as “Intelligent Factory of Henan Province” by the Provincial Industry and Information Technology Commission.

In December 2018, Melan Group's veterinary medicine production base passed the GMP certification of the Ministry of Agriculture.

2019

2019

April 2019 Meilan Group's full series of poultry vaccines launched on the market

July 2019 Awarded as a model enterprise for high quality development of livestock industry in Henan Province

November 2019 Recognized as a new type of R&D institution in Henan Province

2020

2020

In January 2020, the company was honored as one of the “Top 100 Craftsmanship and Intelligence Brands” in Henan Province.

In July 2020, the company was honored as the most influential brand of livestock industry in Henan Province.

In September 2020, the company was honored as a high-tech enterprise.

In November 2020, it was recognized as the Key Laboratory of Livestock and Poultry Intensive Breeding Disease Prevention and Control in Henan Province.

 

2021

2021

December 2021 won the first prize for scientific and technological progress in Shangqiu City, Henan Province, China.

2022

2022

In 2022, Melan Group was granted more than 100 national invention patents, 26 national and provincial achievements, 7 new veterinary drug certificates, and introduced 3 PhDs and 40 masters of high-level talents.

In January 2022, the “Development and Application of New Chinese Medicine Vaccine Free Enhancer Technology” of Melan Bio was awarded the 10th China Innovation and Entrepreneurship Competition.

In March 2022, the project of “a kind of veterinary Chinese medicine immunity enhancer and its application” of Melan Bio won the Shangqiu Patent Award.

In June 2022, the laboratory successfully passed the remote assessment of CNAS accreditation.

In July 2022, Melan Bio was awarded the new version of “Veterinary Drug GMP Certificate of the People's Republic of China” and “Veterinary Drug Production License of the People's Republic of China”.

2023

2023

Completed the research project “Application of key technology of subunit recombinant vaccine for animals” in 2023.

In January 2023, the project “Integration and Application of Key Technologies for Monitoring, Early Warning, Prevention and Control of African Swine Fever and Other Animal Epidemics” was awarded the First Prize of Agricultural Technology Achievement Award of National Agriculture, Animal Husbandry and Fisheries Harvest Prize for the year 2019-2021.

In February 2023, Melan Bio was recognized as “National Enterprise Technology Center”.

In March 2023, Melan Bio was successfully awarded the “Three Standard System Certification” - ISO9001:2015 Quality Management System, ISO14001 Environmental Management System and ISO45001 Occupational Safety Management System.

In May 2023, Melan Bio successfully passed the supervision and inspection of Quality Management Standard for Non-clinical Research of Veterinary Drugs and Quality Management Standard for Clinical Trials of Veterinary Drugs (GCP).

In August 2023, Melan Group's patent “Traditional Chinese Medicine Preparation for Laying Hens and its Preparation Method” was awarded the First Prize of Shangqiu Patent.

In October 2023, Melan passed the on-site evaluation, inspection and audit by CNAS of China National Accreditation Service for Conformity Assessment (CNAS), and the scope of CNAS accreditation covered 35 professional tests in four categories, namely, veterinary biologicals, veterinary pharmaceuticals, animal whole blood and animal serum.

In November 2023, Melan Group was honored with the Outstanding Enterprise Award of the 12th China Innovation and Entrepreneurship Competition Biomedicine National Competition in 2023